Abstract:Obesity has reached pandemic levels and brought increased epidemic of obesity‐related metabolic disorders. Numerous works have reported the preventive effect of omega‐3 fatty acids on the development of obesity. But it is still unclear how omega‐3 fatty acids improve the obesity‐driven homeostatic imbalance. Here we investigated the biological effects of eicosapentaenoic acid (EPA; 20:5n3) and docosahexaenoic acid (DHA; 22:6n3) from long‐term dietary intake on lipid, glucose and energy homeostasis in high‐fat‐diet (HFD) induced obese (DIO) mice. Four‐week‐old C57Bl/6 mice were fed with high‐fat‐diets (HFD; 45% fat) for 10 weeks to introduce obesity. The HFD fed mice were then trisected and fed with DHA or EPA enriched HFD (HFD+DHA or HFD+EPA; 1% wt/wt) or HFD for 15 weeks. DHA or EPA supplementation did not significantly change the bodyweight of mice (HFD+DHA or HFD+EPA vs HFD). Nonetheless, DHA supplementation significantly reduced subcutaneous fat in male mice and both DHA and EPA lowered liver weight in female mice. Interestingly, DHA or EPA administration improved hypercholesterolemia but aggravated hypertriglyceridemia. Importantly, DHA or EPA administration reversed HFD‐induced gut dysbiosis and maintained mucosal thickness followed by alleviated metabolic endotoxemia. Notably, short chain fatty acids (SCFA) production was not affected whereas circulating serotonin was significantly increased in DHA or EPA‐fed mice. In addition, DHA or EPA ameliorated glucose tolerance and insulin resistance through the up‐regulation of Glut4 and phosphorylation of Akt in adipose tissue. Micro‐positron emission tomography/computed tomography (micro‐PET/CT) analysis showed that DHA or EPA administration promoted thermogenesis of brown adipose tissue in both male and female mice. Though oxygen consumption was not affected, DHA or EPA significantly lowered the respiratory exchange ratio (RER) of DIO mice, suggesting enhanced lipid mobilization. In conclusion, these findings reveal the effects of DHA and EPA on obesity‐driven imbalance of lipid, glucose and energy homeostasis and further clinical investigations are warranted to formulate recommendations of DHA and EPA intakes for obese subjects.

12-Hydroxyeicosapentaenoic acid inhibits foam cell formation and ameliorates high-fat diet-induced pathology of atherosclerosis in mice

Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice

Eicosapentaenoic Acid-Enriched Phospholipids Improve Atherosclerosis by Mediating Cholesterol Metabolism

Metabolic Profiling of Murine Plasma Reveals Eicosapentaenoic Acid Metabolites Protecting Against Endothelial Activation and Atherosclerosis.

Hydroxyeicosapentaenoic Acids and Epoxyeicosatetraenoic Acids Attenuate Early Occurrence of Nonalcoholic Fatty Liver Disease

Mussel Oil is Superior to Fish Oil in Preventing Atherosclerosis of ApoE−/− Mice

Omega-3 Polyunsaturated Fatty Acids Antagonize Macrophage Inflammation Via Activation of Ampk/Sirt1 Pathway

Eicosapentaenoic Acid in the Form of Phospholipids Exerts Superior Anti-Atherosclerosis Effects to Its Triglyceride Form in ApoE(-/-) Mice

The Hydrogen Sulfide Donor, Gyy4137, Exhibits Anti-Atherosclerotic Activity in High Fat Fed Apolipoprotein E-/- Mice

Dietary α-Linolenic Acid-Rich Flaxseed Oil Ameliorates High-Fat Diet-Induced Atherosclerosis via Gut Microbiota-Inflammation-Artery Axis in ApoE−/− Mice

8-Hydroxyeicosapentaenoic Acid Decreases Plasma and Hepatic Triglycerides via Activation of Peroxisome Proliferator-Activated Receptor Alpha in High-Fat Diet-Induced Obese Mice

Long-Term Dietary Epa or Dha Supplementation Do Not Ameliorate Obesity but Improve Glucose Homeostasis Via Gut-Adipose Axis in Already Obese Mice

Enhancing PPARγ by HDAC Inhibition Reduces Foam Cell Formation and Atherosclerosis in ApoE Deficient Mice

Protective Role of N6/n3 PUFA Supplementation with Varying DHA/EPA Ratios Against Atherosclerosis in Mice

Flaxseed Oil Containing α -Linolenic Acid Ester of Plant Sterol Improved Atherosclerosis in ApoE Deficient Mice.

Dietary DHA/EPA Ratio Changes Fatty Acid Composition and Attenuates Diet-Induced Accumulation of Lipid in the Liver of ApoE-/- Mice

Dietary Supplementation with Fish Oil Alters the Expression Levels of Proteins Governing Mitochondrial Dynamics and Prevents High-Fat Diet-Induced Endothelial Dysfunction.

Protective effect of α-linolenic acid ester of plant sterol on atherosclerosis in apolipoprotein E deficient mice

Protective role of n6/n3 PUFA supplementation with varying DHA/EPA ratios against atherosclerosis in mice.

Dietary Flaxseed Oil Prevents Western-Type Diet-Induced Nonalcoholic Fatty Liver Disease in Apolipoprotein-E Knockout Mice

Flaxseed Oil Containing Flaxseed Oil Ester of Plant Sterol Attenuates High-Fat Diet-Induced Hepatic Steatosis in Apolipoprotein-E Knockout Mice